When: Reclaim of 10 EMA at $198.78 on volume >3M shares

Then: Upgrade to Hold

When: Fed cut probability >40% OR 10Y holds below 4.25%

Then: Upgrade to Hold

SELL at 25-40% trim to modest underweight; maintain cash buffer; re-enter only on structural confirmation above $208 or positive RSI divergence

• Q3 FY26 showed demand resilience: 8.3% revenue growth, 13.7% operating margin, $3.12B FCF, $4.27 EPS matching prior-year peak
• P/E of 16x represents 30% discount to historical 22-24x multiple and cheapest earnings multiple among peers despite fastest revenue growth
• Company actively deleveraging: $4.4B+ long-term debt repaid in 2026; net debt declining from $34.38B
• Dividend coverage strong: Q3 generated $3.12B FCF against $0.67B dividends (nearly 5x coverage); dividend not at risk at current earnings power
• Annual FCF of $4.62B with 2.55% dividend yield provides fundamental cushion
• 52-week range $188.22 to $293.06; Bollinger lower band at $186.88 is just 2.4% below current price
• Recession odds fell to 8% from 12% week-over-week, reducing tail-risk for earnings cuts and goodwill impairment
• SRS acquisition is strategic response to competitive HD pressure (Pro share wins); betting on integration failure is not a thesis to underwrite
• Lower band at $186.88 should remain a NO-CHASE line; going to zero on lower-band break is tail-risk chasing
• Oppose short exposure and OTM puts since downside scenarios already partially priced; capital better held in cash or short-duration Treasuries

→ vs aggressive: Q3 FY26 was not a 'fadeable head-fake' — operating margin of 13.7%, FCF of $3.12B, and EPS of $4.27 matching prior-year peak demonstrate demand resilience, not inventory liquidation

→ vs aggressive: P/E of 16x in restrictive rate regime is meaningful because multiple has already compressed to reflect rates; 30% discount to historical multiple plus fastest growth is mispricing, not value trap

→ vs aggressive: FCF and leverage concerns overstated — company actively deleveraging with $4.4B+ debt repaid; dividend coverage is 5x and dividend not at risk in 2026

→ vs aggressive: Aggressive technical analysis is selective — ignores Synchrony +8% purchase volume growth, +7.9% YoY August consumer demand, earnings beat, and institutional interest from Dividend King screens

→ vs aggressive: $186.88 lower band break strategy has very poor expected value — level tested multiple times and held; chasing 2.4% break with leveraged downside is asymmetric trade with catastrophic loss risk

→ vs aggressive: Recession odds falling to 8% from 12% is not 'irrelevant noise' — absence of recession tail-risk reduces probability of forced earnings cut, goodwill impairment trigger, and credit deterioration

→ vs aggressive: SRS acquisition framing as 'leverage-on-at-the-top' assumes integration failure; waiting 18 months to evaluate cross-sell and pro-segment expansion is more appropriate than adding put exposure

SELL to trim 25-40% to modest underweight; no-chase at $186.88 lower band; re-enter on close above $200 with 2+ consecutive sessions of declining selling volume and confirmed higher low; allocate 50-60% of freed capital to cash/T-bills, 40-50% to less-correlated defensive positions

• Technical setup is unambiguously bearish: death cross in force all year, MACD accelerating downside, RSI crossing below 30, VWMA at $196.81 confirming volume-weighted selling, institutional distribution on 9/18 and 9/21 high-volume sell days
• Q3 FY26 print is genuinely strong and not acquisition pull-forward: 8.3% revenue, 13.7% operating margins, $3.12 billion FCF against $0.67 billion dividends
• Bearish narrative is substantially priced in: stock down 25.6% from March highs, near 52-week lows, put activity flagged as unusually heavy
• Negative book value at negative $7.44 billion is a real structural constraint on institutional buyer base, not just optics
• SRS acquisition added $8 billion in goodwill, drove stockholders' equity to negative $7.44 billion, and consumes $1.5-1.7 billion in incremental annual interest expense
• Macro is mixed: recession tail-risk fading provides positive optionality for credit/earnings stability but doesn't unlock housing turnover pinned by 96% no-cut probability keeping mortgage rates elevated
• 2.55% dividend yield and 4.3% FCF yield are real but are moving targets as earnings deterioration hasn't fully shown yet and FCF stream faces compression
• Lower band at $186.88 has held multiple times with no technical anchor below it; pre-committing to zero weight on break has poor expected value for a name with $4.6 billion in annual FCF
• Conservative analyst's $208 re-entry trigger is too patient (8-9% above current levels); tighter trigger at $200 with 2+ consecutive sessions of declining selling volume and higher low confirmation is preferred
• 50-60% of freed capital should go to cash/T-bills for optionality; remaining 40-50% should rotate to less-correlated positions like consumer staples, healthcare, or selective industrials

→ vs aggressive: Bearish narrative is NOT underpriced — stock already down 25.6% from March highs near 52-week lows with heavy put activity; adding convex downside exposure is poor expected value as the asymmetric setup exists on the way down, not from current levels

→ vs aggressive: Q3 FY26 print is genuinely strong (8.3% revenue, 13.7% operating margins, $3.12B FCF) not a 'fadeable head-fake'; dismissing it as narrative-engineering is working backward from a thesis

→ vs aggressive: Asking to use derivatives to express a directional view that the underlying equity position already expresses more cheaply is poor trade construction with added cost, time decay, and timing risk

→ vs conservative: Re-entry framework is too patient — $208 trigger is 8-9% above current levels; waiting for 50 SMA reclaim means giving up meaningful ground and treating the technical breakdown as secondary is wrong for a name with these structural constraints

→ vs conservative: 2.55% dividend yield and 4.3% FCF yield are moving targets not a floor — market is pricing in earnings deterioration that hasn't fully shown yet, and SRS acquisition will compress FCF by $1.5-1.7B incrementally

→ vs conservative: SRS acquisition deserves more weight as a drag on equity story for 18-24 months regardless of outcome; framing it as a strategic response worth waiting to see is too generous

→ vs conservative: Putting all freed capital in cash or T-bills ignores diversification benefits; 40-50% should rotate to less-correlated defensive positions rather than sitting entirely in cash for extended period